1. Dr. Maurice George Vincentius Maria Russel
Hofstedeweg 78, 7535 CW, Enschede
Date of birth: 1 March 1958
BIG registration nr: 59023606201
Email: m.russel@mst.nl
Mobile: +316 29355744
PROFESSIONAL EXPERIENCE
2003-Current Medical Spectrum Twente (MST), Dept. of Gastroenterology, Enschede, NL (Netherlands)
Gastroenterologist, area of interest: inflammatory bowel disease (IBD) and colorectal cancer.
Positions:
2014-current: chairman cooperation medical specialists MST
2011-current: chairman of gastroenterology department MST
2007-2011: co-chairman department internal medicine/gastroenterology MST
2003-2012: vice-teacher gastroenterology MST
1996-2003 University Hospital Maastricht, dept. of internal medicine/gastroenterology, Maastricht, NL
Gastroenterologist, staff member (university teacher) gastroenterology
Positions:
2001-2003: board member internal medicine/gastroenterology
1998-2002: internship coordinator internal medicine/gastroenterology
1997-2003: outpatient commission internal medicine/gastroenterology
1997-2003: scientific director European Concerted action on IBD
1996-2003: scientific director South Limburg Project on IBD
FORMAL EDUCATION
1993-1996 University Hospital Maastricht, dept. of gastroenterology,Maastricht,NL
Traineeship gastroenterology
Positions:
1994-1996: tutorabdominal complaints
1993-1996: tutorcomputer assisted education in gastroenterology
1988-1992 Atrium Medical Centre, dept. of internal medicine, Heerlen, NL
Traineeship internal medicine
Positions:
1989-1991: secretary general education/trainee committee
1990-1992: chairman trainee association
1978-1986 Medical study,University of Amsterdam, NL
1977-1978 Medical study,University of Antwerp (Belgium)
1976-1977 Exchange student USA (American Field Service)
1970-1976 Gymnasium B, Roermond, NL
OTHER ADMINISTRATIVE POSITIONS
2010-current Symposium committee, Dutch Society of Gastroenterology
2006-2011 Chairman committee on Quality Affairs, Dutch Society of Gastroenterology
2005-2006 Chairman committee on Guidelines, Dutch Society of Gastroenterology
2004-2006 Member committee of certification, Dutch Society of Gastroenterology
2003-2005 Board member of the Dutch IBD Research Group (Initiative on Crohn and Colitis ICC)
SCIENTIFIC RESEARCH
2014-current IBDREAM study
1997 Thesis: Incidence, Risk factors and Quality of Life in IBD, University of Maastricht, NL
1997-2006 Co-promotor in six theses on IBD, University of Maastricht, NL
1993-current Several (>20) researcher and pharmaceutical initiated studies in the area of IBD
1993-2003 Research in epidemiology and quality of life in IBD
3. Publications (peer reviewed)
Scientific publications
1. van der Wiel SK, Kolkman JJ, Russel MG. Treatment of inflammatory bowel disease: what
if drug therapy fails?.Ned Tijdschr Geneeskd. 2014;158:A7589. Dutch.
2.van Bodegraven AA, Bravenboer N, Witte BI, Dijkstra G, van der Woude CJ, Stokkers PC,
Russel MG, Oldenburg B, Pierik M, Roos JC, van Hogezand RA, Dik VK, Oostlander AE,
Netelenbos JC, van de Langerijt L, Hommes DW, Lips P; Dutch Initiative on Crohn and
Colitis (ICC). Treatment of bone loss in osteopenic patients with Crohn's disease: a double-
blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with
calcium and vitamin D supplementation Gut. 2014 Sep;63(9):1424-30.
3. Guloksuz S, Wichers M, Kenis G, Russel MG, Wauters A, Verkerk R, Arts B, van Os J.
Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan
availability. PLoS One. 2013;8(3):e60435.
4. Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD,
Engels LG, van Deursen C, Hameeteman WH, Pierik M, Wolters F, Russel MG,
Stockbrügger RW. Fatigue and health-related quality of life in inflammatory bowel disease:
results from a population-based study in the Netherlands: the IBD-South Limburg cohort.
Inflamm Bowel Dis. 2010 Dec;16(12):2137-47.
5. van Asseldonk DP, Jharap B, Kuik DJ, de Boer NK, Westerveld BD, Russel MG, Kubben
FJ, van Bodegraven AA, Mulder CJ. Prolonged thioguanine therapy is well tolerated and safe
in the treatment of ulcerative colitis. Dig Liver Dis. 2011 Feb;43(2):110-5.
6. Juillerat P, Pittet V, Mottet C, Felley C, Gonvers JJ, Vader JP, Burnand B, Froehlich F,
Wolters FL, Stockbrügger RW, Michetti P; EC-IBD Group. Appropriateness of early
management of newly diagnosed Crohn's disease in a European population-based cohort.
Scand J Gastroenterol. 2010 Dec;45(12):1449-56.
7. Romberg-Camps MJ, Hesselink-van de Kruijs MA, Schouten LJ, Dagnelie PC, Limonard
CB, Kester AD, Bos LP, Goedhard J, Hameeteman WH, Wolters FL, Russel MG,
Stockbrügger RW.Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991-
2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms.
J Crohns Colitis. 2009 Jun;3(2):115-24.
8. Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M,
Engels LG, Van Deursen C, Hameeteman WH, Wolters FL, Russel MG, Stockbrügger RW.
Influence of phenotype at diagnosis and of other potential prognostic factors on the course of
inflammatory bowel disease. Am J Gastroenterol. 2009 Feb;104(2):371-83.
9. van Hooft JE, Fockens P, Marinelli AW, Timmer R, van Berkel AM, Bossuyt PM,
Bemelman WA; Dutch Colorectal Stent Group. Early closure of a multicenter randomized
clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer.
Endoscopy. 2008 Mar;40(3):184-91.
4. 10. Wolters FL, Joling C, Russel MG, Sijbrandij J, De Bruin M, Odes S, Riis L, Munkholm P,
Bodini P, Ryan B, O'Morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard C,
Vatn M, Fornaciari G, Rodriguez D, Groot W, Moum B, Stockbrügger RW; European
Collaborative Study Group On Inflammatory Bowel Disease (EC-IBD). Treatment inferred
disease severity in Crohn's disease: evidence for a European gradient of disease course.
Scand J Gastroenterol. 2007 Mar;42(3):333-44.
11. Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos
E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van
Zeijl G, O'morain C, Moum B, Vatn M, Stockbrugger R; European Collaborative Study on
Inflammatory Bowel Disease. Cost analysis and cost determinants in a European
inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
Gastroenterology. 2006 Sep;131(3):719-28.
12. Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P,
Langholz E, Bodini P, O'Morain C, Katsanos K, Tsianos E, Vermeire S, Van Zeijl G,
Limonard C, Hoie O, Vatn M, Moum B, Stockbrügger RW; European Collaborative Study
Group On Inflammatory Bowel Disease.Disease outcome of inflammatory bowel disease
patients: general outline of a Europe-wide population-based 10-year clinical follow-up study.
Scand J Gastroenterol Suppl. 2006;(243):46-54.
13. Corporaal S, Smit WM, Russel MG, van der Palen J, Boot H, Legdeur MC. Capecitabine,
epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma. Neth J Med.
2006 May;64(5):141-6.
14. van der Sluijs Veer G, van den Hoven B, Russel MG, van den Bergh FA. Time-resolved
fluorimetric immunoassay of calprotectin: technical and clinical aspects in diagnosis of
inflammatory bowel diseases. Clin Chem Lab Med. 2006;44(3):292-8.
15. Wolters FL, van Zeijl G, Sijbrandij J, Wessels F, O'Morain C, Limonard C,
Russel MG, Stockbrugger RW. Internet-based data inclusion in a population-based European
collaborative follow-up study of inflammatory bowel disease patients: description of methods
used and analysis of factors influencing response rates. World J Gastroenterol.
2005;11(45):7152-8.
16. Goossens DA, Jonkers DM, Russel MG, Stobberingh EE, Stockbrugger RW.
The effect of a probiotic drink with Lactobacillus plantarum 299v on the
bacterial composition in faeces and mucosal biopsies of rectum and ascending
colon. Aliment Pharmacol Ther. 2006;23(2):255-63.
17. Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, Riis L, Langholz E,
Politi P, Qasim A, Koutroubakis I, Tsianos E, Vermeire S, Freitas J, van Zeijl
G, Hoie O, Bernklev T, Beltrami M, Rodriguez D, Stockbrugger RW, Moum B. Phenotype at
diagnosis predicts recurrence rates in Crohn's disease. Gut. 2005 Dec 16;
18. Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm
P, Bodini P, O'morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard
C, Vatn M, Fornaciari G, Pereira S, Moum B, Stockbrugger RW. Crohn's disease: increased
mortality 10 years after diagnosis in a Europe-wide
5. population based cohort. Gut. 2006;55(4):510-8.
19. van der Hagen SJ, Baeten CG, Soeters PB, Beets-Tan RG, Russel MG, van Gemert
WG. Staged mucosal advancement flap for the treatment of complex anal fistulas:
pretreatment with noncutting Setons and in case of recurrent multiple abscesses
a diverting stoma. Colorectal Dis. 2005;7(5):513-8.
20. van der Hagen SJ, Baeten CG, Soeters PB, Russel MG, Beets-Tan RG, van Gemert WG.
Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a
multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's
disease: a preliminary report. Dis Colon Rectum. 2005Apr;48(4):758-67.
21. Goossens D, Jonkers D, Russel M, Thijs A, van den Bogaard A, Stobberingh E,
Stockbrugger R. Survival of the probiotic, L. plantarum 299v and its effects on the faecal
bacterial flora, with and without gastric acid inhibition. Dig LiverDis. 2005;37(1):44-50.
22. Ryan BM, Russel MG, Schurgers L, Wichers M, Sijbrandij J, Stockbrugger RW, Schoon E.
Effect of antitumour necrosis factor-alpha therapy on bone turnover in patients with active
Crohn's disease: a prospective study. Aliment Pharmacol Ther. 2004;20(8):851-7.
23. van der Eijk I, Vlachonikolis IG, Munkholm P, Nijman J, Bernklev T, Politi
P, Odes S, Tsianos EV, Stockbrugger RW, Russel MG; EC-IBD Study Group. The role of
quality of care in health-relatedquality of life in patients with IBD.
Inflamm Bowel Dis. 2004;10(4):392-8.
24. Wolters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in
Crohn's disease changed during the last four decades? Aliment Pharmacol Ther.
2004;20(5):483-96.
25. Van Der Eijk I, Verheggen FW, Russel MG, Buckley M, Katsanos K, Munkholm P, Engdahl
I, Politi P, Odes S, Fossen J, StockbruggerRW; European Collaborative
Study Group on Inflammatory Bowel Disease (EC-IBD). "Best practice" in inflammatory
bowel disease: an international survey and audit. Eur J Intern Med. 2004;15(2):113-120.
26. Goossens D, JonkersD, StobberinghE, van den Bogaard A, Russel M,
Stockbrugger R. Probiotics in gastroenterology: indications and future perspectives. Scand
J Gastroenterol Suppl. 2003;(239):15-23.
27. van den Bergh FA, KolkmanJJ, Russel MG, Vlaskamp RT, VermesI.
[Calprotectin: a fecal markerfordiagnosis and follow-upin patients with
chronic inflammatory bowel disease] Ned Tijdschr Geneeskd. 2003;147(48):2360-5.
Dutch.
28. GoossensD, Jonkers D, Russel M, Stobberingh E, Van Den Bogaard A, Stockbrugger R.
The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic
activity in faeces of healthy volunteers: a placebo-controlled study on the onset and
duration of effects.Aliment Pharmacol Ther. 2003 Sep1;18(5):495-505.
6. 29. Ryan BM, Russel MG, Langholz E, Stockbrugger RW. Aminosalicylates and colorectal
cancer in IBD: a not-so bitter pill to swallow. Am J Gastroenterol. 2003;98(8):1682-7.
30. Russel MG, Ryan BM, Dagnelie PC, de Rooij M, Sijbrandij J, Feleus A, Hesselink M, Muris
JW, Stockbrugger R. Insurance problems among inflammatory bowel disease patients:
results of a Dutch population based study. Gut. 2003;52(3):358-62.
31. Boonen A, Dagnelie PC, Feleus A, Hesselink MA, MurisJW, Stockbrugger RW,
Russel MG. The impact of inflammatory bowel diseaseon laborforceparticipation: results
of a population sampled case-control study. Inflamm Bowel Dis. 2002;8(6):382-9.
32. DamoiseauxJG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG,
Forget PP, Tervaert JW. Diagnostic value of anti-Saccharomyces cerevisiae and
antineutrophil
cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with
celiac disease.J Clin Immunol. 2002;22(5):281-8.
33. van Balkom BP, Schoon EJ, Stockbrugger RW, Wolters FL, van HogezandRA, van
Deventer SJ, Oldenburg B, van Dullemen HM, Russel MG. Effects of anti-tumour necrosis
factor-alpha therapy on thequality oflife in Crohn's disease.
Aliment Pharmacol Ther. 2002;16(6):1101-7.
34. van der Eijk I, Sixma H, Smeets T, Veloso FT, Odes S, Montague S, Fornaciari G, Moum B,
StockbruggerR, Russel M; European Collaborative Study Group on IBD.
Quality of health care in inflammatory bowel disease: development of a reliable
questionnaire (QUOTE-IBD) and first results. Am J Gastroenterol. 2001 Dec;96(12):3329-
36.
35. Salvarani C, Vlachonikolis IG, vanderHeijde DM, Fornaciari G, Macchioni
P, Beltrami M, Olivieri I, Di Gennaro F, Politi P, Stockbrugger RW, Russel MG;
European Collaborative IBD Study Group. Musculoskeletal manifestations in a population-
based cohort of inflammatory bowel disease patients. Scand J Gastroenterol.
2001;36(12):1307-13.
36. Russel MG, Stockbrugger RW.
[Epidemiological developments andinsights in chronic inflammatory bowel
diseases] Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1448-52. Review.
37. Fornaciari G, Salvarani C, Beltrami M, Macchioni P, Stockbrugger RW, Russel
MG. Muscoloskeletal manifestations in inflammatory bowel disease. Can J Gastroenterol.
2001 Jun;15(6):399-403.
38. Schoon EJ, van Nunen AB, WoutersRS, Stockbrugger RW, Russel MG.
Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch
population-based cohort. Scand J Gastroenterol Suppl. 2000;(232):43-7.
39. Witte J, Shivananda S, Lennard-JonesJE, Beltrami M, Politi P, Bonanomi A,
Tsianos EV, Mouzas I, Schulz TB, Monteiro E, Clofent J, Odes S, Limonard CB,
7. Stockbrugger RW, Russel MG. Disease outcome in inflammatory bowel disease: mortality,
morbidity and therapeutic management of a 796-person inception cohort in the European
Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol.
2000;35(12):1272-7.
40. Schoon EJ, Blok BM, Geerling BJ, Russel MG, StockbruggerRW, BrummerRJ.
Bone mineral density in patients with recently diagnosedinflammatory bowel
disease. Gastroenterology. 2000;119(5):1203-8.
41. van der Eijk I, Stockbrugger R, Russel M. Influence of quality of care on quality of life in
inflammatory bowel disease (IBD): literaturereview and studies planned.
Eur J Intern Med. 2000;11(4):228-234.
42. Russel MG. Changes in the incidence of inflammatory bowel disease: what does it
mean?
Eur J Intern Med. 2000;11(4):191-196.
43. Stockbrugger RW, Russel MG, van Blankenstein M, Shivananda S. EC-IBD: a European
effort in inflammatory bowel disease. Eur J Intern Med. 2000;11(4):187-190.
44. Geerling BJ, Badart-Smook A, van Deursen C, van Houwelingen AC, Russel MG,
Stockbrugger RW, Brummer RJ. Nutritional supplementation with N-3 fatty acids and
antioxidants in patients with Crohn's disease in remission: effects on antioxidant status
and fatty acid profile. Inflamm Bowel Dis. 2000;6(2):77-84.
45.: Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, StockbruggerRW,
Brummer RJ. Diet as a risk factor for the development of ulcerative colitis. Am J
Gastroenterol. 2000;95(4):1008-13.
46. Russel MG, StockbruggerRW. Is appendectomy a causative factorin ulcerative colitis?
Eur J Gastroenterol Hepatol. 1998 ;10(6):455-7.
47. Russel MG, Volovics A, Schoon EJ, vanWijlick EH, Logan RF, Shivananda S,
Stockbrugger RW. Inflammatory bowel disease: is there any relation between smoking
status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel
Dis. 1998;4(3):182-6.
48. Russel MG, Engels LG, Muris JW, Limonard CB, Volovics A, BrummerRJ,
Stockbrugger RW. Modern life' in the epidemiology of inflammatory bowel disease: a case-
control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol.
1998 Mar;10(3):243-9.
49. Russel MG, Dorant E, Volovics A, Brummer RJ, Pop P, Muris JW, Bos LP, Limonard CB,
Stockbrugger RW. High incidence of inflammatory bowel disease in The Netherlands:
results of a prospective study. The South Limburg IBD Study Group.Dis Colon Rectum.
1998;41(1):33-40.
50. Russel MG, Dorant E, Brummer RJ, van de Kruijs MA, Muris JW, BergersJM,
8. Goedhard J, Stockbrugger RW. Appendectomy and the risk of developing ulcerative colitis
or Crohn's disease: results of a large case-control study. South Limburg Inflammatory
Bowel Disease StudyGroup. Gastroenterology. 1997;113(2):377-82.
51. Russel MG, Pastoor CJ, Brandon S, Rijken J, Engels LG, vanderHeijde DM,
StockbruggerRW. Validation of the Dutch translation ofthe Inflammatory Bowel Disease
Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel
disease. Digestion. 1997;58(3):282-8.
52. Russel MG, Pastoor CJ, Janssen KM, vanDeursen CT, Muris JW, van Wijlick
EH, Stockbrugger RW. Familial aggregation of inflammatory bowel disease: a population-
based study in South Limburg, The Netherlands. The South Limburg IBD Study Group.
Scand J Gastroenterol Suppl. 1997;223:88-91.
53. Russel MG, Nieman FH, Bergers JM, Stockbrugger RW. Cigarette smoking and quality of
life in patients with inflammatory bowel disease. South Limburg IBD Study Group. Eur J
Gastroenterol Hepatol. 1996; 8(11):1075-81.
54. Russel MG, Stockbrugger RW. Epidemiology ofinflammatory bowel disease: an update.
Scand J Gastroenterol. 1996;31(5):417-27.
55. Russel MG, Zeijen RN, BrummerRJ, de BruineAP, van Kroonenburgh MJ,
Stockbrugger RW. Eosinophilic enterocolitis diagnosed by means of technetium-99m
albumin
scintigraphy and treated with budesonide (CIR). Gut. 1994;35(10):1490-2.
56. Russel MG, Lustermans FA, Wuite J, van Pelt J. Porphyria cutanea tarda in a patient
with AIDS. Neth J Med. 1992;41(1-2):68-70.
57. van Wersch JW, Russel MG, Lustermans FA.The extent of diffuse intravascular
coagulation and fibrinolysis in patients with liver cirrhosis. Eur J Clin Chem Clin Biochem.
1992;30(5):275-9.
Thesis
Incidence, risk factors and quality of life in IBD; Inflammatory Bowel Disease Registry
South Limburg, juli 1997, University of Maastricht.
Book contribution
Van Deventer SJH, Russel MG. Inflammatory Bowel Disease. In: Lanschot JJB, Gouma DJ,
Jansen PLM et al. Intergrated Medical and Surgical Gastroenterology. Bohn Stafleu Van
Loghum, 2004.
